A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W |
A list of those drugs available for prescription (by NHS Trusts in the UK), reimbursement under a health insurance plan or offered under a capitated or managed care programme, or preferred in a particular clinical setting. Usually drawn up as cost-containment measures and widely encouraged, the aims of a formulary are usually said to be to promote safe, rational and cost effective prescribing.
See also:
National Health Service (NHS)
Prescription only medicine (POM)
Health Care Financing Administration (HCFA) (US)
Cost-effectiveness threshold (health economics)
Phase II trials, Brief summary, e-Detailing, Leader pricing, Control group, Blind (clinical trial terms), Health state, Quality assurance programme, Prescribing Analysis and Cost (PACT), Side-effects, Primary Care Trust (PCT), Department of Health (DH), Informed consent document, Utility (pharmacoeconomics), Institutional review board (IRB) - pharmacoeconomics,
Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and...